glp 1 and gip agonist New strategies for the treatment of obesity metabolic dysfunctions The Emerging Role of Dual
Description
doi: 10.1152/physrev.00013.2014
GLP-1 drugs mimic a hormone the body produces after eating, which can decrease appetite and lead to feelings of fulness a major reason people lose weight
VFA, visceral fat area
Parizad et al., 2025)
The side effect profile is well-characterized: nausea, constipation , and gastrointestinal discomfort are the most common issues, typically resolving within the first 4-8 weeks
The point is to make the GLP-1 journey easier to understand and stay with
